1 week ago
Recently Dr. Marc Bjurlin joined leading experts from around the world in Milan, Italy, for the 10th European Conference on Tobacco or Health (ECToH) – one of the premier international forums dedicated to advancing tobacco control, prevention, and public health policy.
1 month ago
As colleagues gather in Washington this spring, attendees moving from session to session will encounter a consistent presence from UNC Urology. Their participation across the 2026 AUA Annual Meeting reflects the ongoing work taking place within our department – work that spans clinical care, research, and education and connects UNC Urology to the broader national community of physicians and scientists advancing the field.
2 months ago
UNC Urology continues to expand treatment options for patients with bladder cancer by offering several newly FDA-approved therapies—many of which were previously available through clinical trials conducted at UNC.
2 months ago
We are pleased to share that Dr. Marc Bjurlin has been named to the 2026 Castle Connolly Top Doctors list for the first time.
3 months ago
The Department of Urology at the UNC School of Medicine has been designated an official Single-Port (SP) Robotic Surgery Case Observation Site, placing UNC among fewer than 20 programs nationwide to receive this distinction from Intuitive.
6 months ago
UNC physician Marc Bjurlin teamed up with his colleagues from the Clinical Trialist Training Program on a unique series of studies aimed at improving and expanding clinical trials.
1 year ago
In a recent episode of the Bladder Cancer Matters podcast titled “Unpacking Smoking and Bladder Cancer,” Dr. Marc Bjurlin shared critical insights into the connection between smoking and bladder cancer.
1 year ago
UNC Urology is proud to announce that Marc Bjurlin, DO, MSc, FACOS, has been appointed the department's Vice Chair of Research, a role that will further elevate our research mission and commitment to advancing urologic care.
1 year ago
Robotic Assisted Laparoscopic Prostatectomy (RALP) is a minimally invasive surgery for men with prostate cancer. The procedure involves making a series of small holes in the abdomen through which robotic arms controlled by the surgeon are used to remove the prostate with a high degree of accuracy and precision. RALP is now the most common type of prostatectomy performed in the U.S.
1 year ago
UNC Urology is proud to recognize Dr. Marc Bjurlin for his contributions as an invited speaker at the 11th Symposium of the Oncological Urology Section of the Polish Urological Society held in Warsaw, Poland.
2 years ago
Congratulations to Heather Schultz, NP, FAUNA, Marc Bjurlin, DO, MSc, FACOS, and Dr. Matthew Nielsen, MD, MS, FACS for receiving the UNC Health 2024 "Award for Carolina Excellence”
2 years ago
A multi-center Phase 3 clinical trial named “QUILT” is exploring a potential new treatment that involves administering BCG (Bacillus Calmette-Guerin) combined with an experimental drug known as N-803 (Nogapendekin alfa inbakicept), with the goal of providing a synergistic therapeutic effect to some Bladder Cancer patients.